Discovery of isocodonocarpine and sophoronol from Thai medicinal herbs as potential inhibitors of SARS-CoV-2 main protease: a molecular modeling perspective
Aug 2026· Chemical Monthly· Vol 157, pp. 1273 - 1288· 0 citations· 80 references
TL;DR
It is suggested that ISO and SOP are promising candidates for SARS-CoV-2 Mpro inhibition, warranting further validation through in vitro and in vivo studies.
Overall, vitexin shows promising binding characteristics as a natural compound targeting Mpro, but it does not surpass the native ligand in terms of overall binding stability, warranting further optimization and experimental validation.
Syahida Djasang, Artati Artati· Journal of the Turkish Chemi...· 0 citations
Seven para-substituted flavonoid hybrids against the main protease (Mpro) are designed and M6 is prioritized as a computational lead requiring Mpro inhibition, antiviral, and cytotoxicity validation.
Jawaher H. Alqahtani, Mohammed Ouachekradi, Bahia Abdelfattah et al.· Current Issues in Molecular...· 0 citations
The SARS-CoV-2 main protease (Mpro) plays a crucial role in viral replication, making it an attractive target for antiviral drug development. This study evaluates the inhibitory potential of nineteen 6-substituted coumarin derivatives (1a–p and 2a–c) against Mpro using a FRET-based enzymatic assay. Among them, the chlo...
Ashraf K. El-Damasy, Md Sofequl Islam Mukim, Sangeun Jeon et al.· RSC Advances· 0 citations
The findings suggest that Lig-1, followed by Lig-3, may serve as promising computational lead compounds targeting SARS-CoV-2 MPro, representing promising candidates for further experimental validation.
Mohd Yasir Khan, Farah Maarfi, A. Shah et al.· International Journal of Mol...· 0 citations
Background/Objectives: SARS-CoV-2, the causative agent of COVID-19, relies on its main protease (Mpro) for viral replication, making this enzyme an attractive target for antiviral drug development. In the present study, we investigated whether a library of previously synthesized thiazole/benzothiazole-based thiazolidin...
A. Petrou, Aliki Papadimitriou-Tsantarliotou, Hathaichanok Chuntakaruk et al.· The biochemist· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.